{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":26,"n_cols":5,"rows_kept":26,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[10,2,10,3],[11,2,11,3],[12,2,12,3],[13,2,13,3],[16,2,16,3],[17,2,17,3],[22,2,22,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9911019615503321"]
[null,null,"Titolo",null,"Vaccines against virally induced cancers"]
[null,null,"Pubbl/distr/stampa",null,"Chichester ; ; New York, : J. Wiley, 1994"]
[null,null,"ISBN",null,"9786612137921"]
[{"$nulls":4},"9781282137929"]
[{"$nulls":4},"1282137921"]
[{"$nulls":4},"9780470514672"]
[{"$nulls":4},"0470514671"]
[{"$nulls":4},"9780470514689"]
[{"$nulls":4},"047051468X"]
[null,null,"Descrizione fisica",null,"1 online resource (293 p.)"]
[null,null,"Collana",null,"Ciba Foundation symposium ; ; 187"]
[null,null,"Disciplina",null,"616.99/4079"]
[null,null,"Soggetti",null,"Viral carcinogenesis"]
[{"$nulls":4},"Viral vaccines"]
[{"$nulls":4},"Cancer - Immunotherapy"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","\"Ciba Foundation\"--Cover."]
[{"$nulls":4},"Symposium held at the Ciba Foundation, London, 15-17 March 1994, based on a proposal by Ian Frazer."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and indexes."]
[null,null,"Nota di contenuto",null,"VACC I N ES AGAl NST VIRALLY INDUCED CANCERS; Contents; Participants; Introdu ction; Potential antigenic targets on Epstein - Bar r vir us-associated tumours and the host response; The host response to lesions induced by human papillomavirus; General discussion I; Human T cell lymphotropic virus: necessity for and feasibility of a vaccine; Vaccination against cutaneous and mucosal papillomavirus in cattle; Strategies for studying mouse and human immune responses to human papillomavirus type 16"]
[{"$nulls":4},"Prospects for T cell immunotherapy of tumours by vaccination with immunodominant and su bdominant peptidesHepatitis B virus infection, the immune response and hepatocellular carcinoma; The role of superantigens in the immunobiology of retroviruses; General discussion I I; Assembly and transport of class I MHC-peptide complexes; Induction and regulation of CD4+ T cell subsets; Propagation of mouse and human T cells with defined antigen specificity and function; Immunity to the HER-2heu oncogenic protein"]
[{"$nulls":4},"Genetic modification of T cell clones to improve the safety and efficacy of adoptive T cell therapyBone marrow-derived cells present MHC class I-restricted tumour antigens in priming of antiturnour immune responses; Evasion of host immune responses by tumours and viruses; Final dscussion; Index of contributors; Subject index"]
[null,null,null,"Sommario/riassunto","An interdisciplinary and multinational group of specialists present contributions describing the current status of vaccines against virally induced tumors and discuss the means by which they can be improved."]